Pages that link to "Q39741489"
Jump to navigation
Jump to search
The following pages link to Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells (Q39741489):
Displaying 50 items.
- Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal (Q26744536) (← links)
- Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks (Q26752554) (← links)
- Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway (Q26797238) (← links)
- Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid (Q26799981) (← links)
- Role of TGFβ in regulation of the tumor microenvironment and drug delivery (review) (Q28081170) (← links)
- The roles of TGFβ in the tumour microenvironment (Q33630845) (← links)
- Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation (Q34163525) (← links)
- Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. (Q34796473) (← links)
- Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer (Q35052004) (← links)
- The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells (Q35164602) (← links)
- Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers (Q35490960) (← links)
- Increased Expression of TGFβR2 Is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients Treated with Chemotherapy (Q35739691) (← links)
- Blockage of TGFβ-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo (Q35763804) (← links)
- Anti-TGF-β antibody combined with dendritic cells produce antitumor effects in osteosarcoma (Q36083713) (← links)
- TCR signaling intensity controls CD8+ T cell responsiveness to TGF-β. (Q36143408) (← links)
- TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma. (Q36339786) (← links)
- Protein Markers Associated with an ALDH Sub-Population in Colorectal Cancer. (Q36371449) (← links)
- Targeting the TGFβ signalling pathway in disease (Q36462348) (← links)
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer (Q36638173) (← links)
- Cancer vaccines: Looking to the future (Q36866158) (← links)
- TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. (Q37048061) (← links)
- The polarization of immune cells in the tumour environment by TGFbeta (Q37454364) (← links)
- Effective chemoimmunotherapy with anti-TGFβ antibody and cyclophosphamide in a mouse model of breast cancer (Q37459043) (← links)
- Exploring anti-TGF-β therapies in cancer and fibrosis. (Q37896073) (← links)
- Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. (Q37916975) (← links)
- TGFβ: A player on multiple fronts in the tumor microenvironment. (Q38241602) (← links)
- The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis (Q38291631) (← links)
- A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors. (Q38379618) (← links)
- MOLECULAR PATHWAYS: TARGETING THE MICROENVIRONMENT OF LIVER METASTASES. (Q38671001) (← links)
- Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling (Q38874118) (← links)
- Signaling Receptors for TGF-β Family Members (Q38915720) (← links)
- Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis (Q38971921) (← links)
- Immunoregulation by members of the TGFβ superfamily (Q39019244) (← links)
- Dichotomous roles of TGF-β in human cancer (Q39027205) (← links)
- Targeting TGF-β Signaling for Therapeutic Gain (Q39155151) (← links)
- A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo (Q39251935) (← links)
- Targeting TGF-β Signaling in Cancer (Q39441327) (← links)
- The role of transforming growth factor-β in suppression of hepatic metastasis from colon cancer (Q39659843) (← links)
- TGFβ1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer (Q41481557) (← links)
- Stromal TGFβR2 signaling: a gateway to progression for pancreatic cancer (Q42730684) (← links)
- 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland (Q42732008) (← links)
- Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor. (Q50173304) (← links)
- Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts. (Q55068795) (← links)
- Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade. (Q55491725) (← links)
- The Role of Tumor-Associated Neutrophils in Colorectal Cancer (Q64273921) (← links)
- Epithelial-mesenchymal transition: a new target in anticancer drug discovery (Q87179773) (← links)
- Recent Advances in Understanding Mechanisms of TGF Beta Signaling and Its Role in Glioma Pathogenesis (Q89604996) (← links)
- Targeting TGFβR2-mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer (Q90687457) (← links)
- Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer (Q92042963) (← links)
- A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy (Q93027444) (← links)